Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Pitroda

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Cancer Research|January 16, 2021
(Oligo)metastasis as a Spectrum of DiseaseStanley I Gutiontov, Sean P Pitroda, Phuoc T Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic DiseaseConnor Lynch, Muzamil Arshad, Rohan R Katipally, et al.
Oncotarget|March 13, 2025
No disease left behindMuzamil Arshad, Connor Lynch, Rohan R Katipally, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2017
Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast CancerSean P Pitroda, Riyue Bao, Jorge Andrade, et al.
Nature Reviews. Clinical Oncology|July 13, 2022
The oligometastatic spectrum in the era of improved detection and modern systemic therapyRohan R Katipally, Sean P Pitroda, Aditya Juloori, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2020
Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation TherapyStanley I Gutiontov, Sean P Pitroda, Steven J Chmura, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatmentSean P Pitroda, Nikolai N Khodarev, Michael A Beckett, et al.
Clinical Genitourinary Cancer|May 23, 2024
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone AgonistsGreeshma Rajeev-Kumar, Sean P Pitroda, Russell Z Szmulewitz, et al.
Med (New York, N.Y.)|December 9, 2023
RNA m<sup>6</sup>A methylation and MDSCs: Roles and therapeutic implications for radiotherapyLiangliang Wang, Rohan R Katipally, Hua Laura Liang, et al.
Science Translational Medicine|March 28, 2014
DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapySean P Pitroda, Itai M Pashtan, Hillary L Logan, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Cancer Research|January 16, 2021
(Oligo)metastasis as a Spectrum of DiseaseStanley I Gutiontov, Sean P Pitroda, Phuoc T Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic DiseaseConnor Lynch, Muzamil Arshad, Rohan R Katipally, et al.
Oncotarget|March 13, 2025
No disease left behindMuzamil Arshad, Connor Lynch, Rohan R Katipally, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2017
Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast CancerSean P Pitroda, Riyue Bao, Jorge Andrade, et al.
Nature Reviews. Clinical Oncology|July 13, 2022
The oligometastatic spectrum in the era of improved detection and modern systemic therapyRohan R Katipally, Sean P Pitroda, Aditya Juloori, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2020
Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation TherapyStanley I Gutiontov, Sean P Pitroda, Steven J Chmura, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatmentSean P Pitroda, Nikolai N Khodarev, Michael A Beckett, et al.
Clinical Genitourinary Cancer|May 23, 2024
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone AgonistsGreeshma Rajeev-Kumar, Sean P Pitroda, Russell Z Szmulewitz, et al.
Med (New York, N.Y.)|December 9, 2023
RNA m<sup>6</sup>A methylation and MDSCs: Roles and therapeutic implications for radiotherapyLiangliang Wang, Rohan R Katipally, Hua Laura Liang, et al.
Science Translational Medicine|March 28, 2014
DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapySean P Pitroda, Itai M Pashtan, Hillary L Logan, et al.
Pageof 9